Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.

It also shows that molecules known as BH3 mimetics can improve the effect ... a fusion of two genes — ALK and the EML4 gene in 90% of cases — results in a new gene capable of encoding a ...